258 related articles for article (PubMed ID: 20023744)
1. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides.
Aguilera TA; Olson ES; Timmers MM; Jiang T; Tsien RY
Integr Biol (Camb); 2009 Jun; 1(5-6):371-81. PubMed ID: 20023744
[TBL] [Abstract][Full Text] [Related]
2. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer.
Olson ES; Aguilera TA; Jiang T; Ellies LG; Nguyen QT; Wong EH; Gross LA; Tsien RY
Integr Biol (Camb); 2009 Jun; 1(5-6):382-93. PubMed ID: 20023745
[TBL] [Abstract][Full Text] [Related]
3. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
J Nucl Med; 2011 Feb; 52(2):279-86. PubMed ID: 21233187
[TBL] [Abstract][Full Text] [Related]
4. Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.
Shi NQ; Gao W; Xiang B; Qi XR
Int J Nanomedicine; 2012; 7():1613-21. PubMed ID: 22619516
[TBL] [Abstract][Full Text] [Related]
5. Tumor imaging by means of proteolytic activation of cell-penetrating peptides.
Jiang T; Olson ES; Nguyen QT; Roy M; Jennings PA; Tsien RY
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17867-72. PubMed ID: 15601762
[TBL] [Abstract][Full Text] [Related]
6. The targeted transduction of MMP-overexpressing tumor cells by ACPP-HPMA copolymer-coated adenovirus conjugates.
Li S; Chen J; Xu H; Long J; Xie X; Zhang Y
PLoS One; 2014; 9(7):e100670. PubMed ID: 25000246
[TBL] [Abstract][Full Text] [Related]
7. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
[TBL] [Abstract][Full Text] [Related]
8. In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
Contrast Media Mol Imaging; 2015; 10(1):59-66. PubMed ID: 24823643
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
10. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
11. Acid-sensitive hybrid polymeric micelles containing a reversibly activatable cell-penetrating peptide for tumor-specific cytoplasm targeting.
Tang B; Zaro JL; Shen Y; Chen Q; Yu Y; Sun P; Wang Y; Shen WC; Tu J; Sun C
J Control Release; 2018 Jun; 279():147-156. PubMed ID: 29653223
[TBL] [Abstract][Full Text] [Related]
12. Parallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptides.
Whitney M; Crisp JL; Olson ES; Aguilera TA; Gross LA; Ellies LG; Tsien RY
J Biol Chem; 2010 Jul; 285(29):22532-41. PubMed ID: 20460372
[TBL] [Abstract][Full Text] [Related]
13. [The application of enzyme-sensitive activatable cell-penetrating peptides to targeted delivery system].
He F; Cao L; Zhang XJ; Xiang B; Cao DY; Qi XR
Yao Xue Xue Bao; 2015 Feb; 50(2):141-7. PubMed ID: 25975019
[TBL] [Abstract][Full Text] [Related]
14. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
Elife; 2021 Oct; 10():. PubMed ID: 34713805
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial cell penetrating peptides with bacterial cell specificity: pharmacophore modelling, quantitative structure activity relationship and molecular dynamics simulation.
Faya M; Kalhapure RS; Dhumal D; Agrawal N; Omolo C; Akamanchi KG; Govender T
J Biomol Struct Dyn; 2019 Jun; 37(9):2370-2380. PubMed ID: 30047310
[TBL] [Abstract][Full Text] [Related]
16. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival.
Nguyen QT; Olson ES; Aguilera TA; Jiang T; Scadeng M; Ellies LG; Tsien RY
Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4317-22. PubMed ID: 20160097
[TBL] [Abstract][Full Text] [Related]
17. Protease-Activable Cell-Penetrating Peptide-Protoporphyrin Conjugate for Targeted Photodynamic Therapy in Vivo.
Li SY; Cheng H; Qiu WX; Liu LH; Chen S; Hu Y; Xie BR; Li B; Zhang XZ
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28319-29. PubMed ID: 26634784
[TBL] [Abstract][Full Text] [Related]
18. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.
Olson ES; Whitney MA; Friedman B; Aguilera TA; Crisp JL; Baik FM; Jiang T; Baird SM; Tsimikas S; Tsien RY; Nguyen QT
Integr Biol (Camb); 2012 Jun; 4(6):595-605. PubMed ID: 22534729
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating peptides and their analogues as novel nanocarriers for drug delivery.
Jafari S; Maleki Dizaj S; Adibkia K
Bioimpacts; 2015; 5(2):103-11. PubMed ID: 26191505
[TBL] [Abstract][Full Text] [Related]
20. Pediatric atypical choroid plexus papilloma: Clinical features and diagnosis.
Chen Y; Zhao R; Shi W; Li H
Clin Neurol Neurosurg; 2021 Jan; 200():106345. PubMed ID: 33203591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
